CDXS
Price
$2.67
Change
+$0.09 (+3.49%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
221.2M
22 days until earnings call
JANX
Price
$24.50
Change
+$0.54 (+2.25%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
1.45B
35 days until earnings call
Interact to see
Advertisement

CDXS vs JANX

Header iconCDXS vs JANX Comparison
Open Charts CDXS vs JANXBanner chart's image
Codexis
Price$2.67
Change+$0.09 (+3.49%)
Volume$5.73K
Capitalization221.2M
Janux Therapeutics
Price$24.50
Change+$0.54 (+2.25%)
Volume$6.04K
Capitalization1.45B
CDXS vs JANX Comparison Chart in %
Loading...
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDXS vs. JANX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDXS is a StrongBuy and JANX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (CDXS: $2.67 vs. JANX: $24.45)
Brand notoriety: CDXS and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDXS: 52% vs. JANX: 82%
Market capitalization -- CDXS: $221.2M vs. JANX: $1.45B
CDXS [@Biotechnology] is valued at $221.2M. JANX’s [@Biotechnology] market capitalization is $1.45B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDXS’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • CDXS’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, CDXS is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDXS’s TA Score shows that 5 TA indicator(s) are bullish while JANX’s TA Score has 6 bullish TA indicator(s).

  • CDXS’s TA Score: 5 bullish, 4 bearish.
  • JANX’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, JANX is a better buy in the short-term than CDXS.

Price Growth

CDXS (@Biotechnology) experienced а +11.25% price change this week, while JANX (@Biotechnology) price change was +5.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

CDXS is expected to report earnings on Jul 31, 2025.

JANX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.45B) has a higher market cap than CDXS($221M). CDXS YTD gains are higher at: -44.025 vs. JANX (-55.248). CDXS has higher annual earnings (EBITDA): -62.28M vs. JANX (-111.54M). JANX has more cash in the bank: 1.01B vs. CDXS (59.8M). JANX has less debt than CDXS: JANX (22.6M) vs CDXS (59.5M). CDXS has higher revenues than JANX: CDXS (49.8M) vs JANX (9.34M).
CDXSJANXCDXS / JANX
Capitalization221M1.45B15%
EBITDA-62.28M-111.54M56%
Gain YTD-44.025-55.24880%
P/E RatioN/AN/A-
Revenue49.8M9.34M533%
Total Cash59.8M1.01B6%
Total Debt59.5M22.6M263%
FUNDAMENTALS RATINGS
CDXS: Fundamental Ratings
CDXS
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDXSJANX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 6 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CDXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCNNF4.210.31
+8.06%
Trulieve Cannabis Corporation
TGHLF1.350.02
+1.54%
Tornado Infrastructure Equipment Ltd.
OLVRF0.03N/A
N/A
Olivut Resources Ltd.
VOYJF27.07N/A
N/A
Valmet OYJ
TRPCF56.84N/A
N/A
Trip.com Group Limited

CDXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDXS has been loosely correlated with DNLI. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CDXS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDXS
1D Price
Change %
CDXS100%
+3.49%
DNLI - CDXS
51%
Loosely correlated
+0.56%
BEAM - CDXS
51%
Loosely correlated
+5.84%
PRAX - CDXS
49%
Loosely correlated
+0.17%
CRSP - CDXS
49%
Loosely correlated
+7.09%
CRBU - CDXS
47%
Loosely correlated
+15.11%
More